Murae Organisor

Which are the latest news on Murae Organisor?

Why is Murae Organisor Ltd falling/rising?

As of 05-Sep, Murae Organisor Ltd's stock price is at 0.19, unchanged from the previous session. The stock has significantly underperformed, with a year-to-date decline of 26.92% and a 75.00% drop over the past year, reflecting low investor confidence and a bearish trend.

As of 05-Sep, Murae Organisor Ltd's stock price is currently at 0.19, showing no change from the previous trading session. The stock has been underperforming significantly compared to the benchmark Sensex, with a year-to-date decline of 26.92% against the Sensex's 10.21% drop. Over the past year, the stock has fallen by 75.00%, while the Sensex has only decreased by 5.21%. <BR><BR>Today's performance indicates that the stock has hit a new 52-week and all-time low of Rs. 0.19, reflecting a lack of investor confidence. Additionally, Murae Organisor is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a bearish trend. <BR><BR>Investor participation has also declined, with delivery volume falling by 19.13% compared to the 5-day average, indicating reduced trading activity and interest in the stock. Overall, these factors contribute to the stock's downward trajectory, highlighting a persistent decline in value and investor sentiment.

Who are in the management team of Murae Organisor?

The management team of Murae Organisor includes Bhumishth Narendrabhai Patel (Chairman & Managing Director), Payal Bhumishth Patel (Whole Time Director & CFO), and several independent and additional directors, overseeing the company's strategic direction and governance.

The management team of Murae Organisor includes the following individuals:<BR><BR>1. **Bhumishth Narendrabhai Patel** - Chairman & Managing Director<BR>2. **Payal Bhumishth Patel** - Whole Time Director & CFO<BR>3. **Bhavik Shantilal Patel** - Independent Director<BR>4. **Dahyabhai Mafatlal Patel** - Additional Non-Executive Director<BR>5. **Parimal S Patwa** - Additional Independent Director<BR>6. **Harsh M Kothari** - Additional Independent Director<BR>7. **Madhuri Mistry** - Company Secretary & Compliance Officer<BR>8. **Sumitkumar Patel** - Independent Director<BR>9. **Premaram Patel** - Additional Director<BR>10. **Sanjaykumar Nai** - Additional Director<BR>11. **Vijaykumar Patel** - Additional Director<BR><BR>This team oversees the strategic direction and governance of the company.

What does Murae Organisor do?

Murae Organisor Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 4 Cr and a net profit of 7 Cr for June 2025. It has a market cap of INR 39 Cr, a P/E ratio of 3.00, and a return on equity of 7.29%.

Overview: <BR>Murae Organisor Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>Murae Organisor Limited was originally incorporated as "Earum Pharmaceuticals Private Limited" in 2012. The company transitioned to a Public Limited status and changed its name to "Earum Pharmaceuticals Limited" on January 23, 2019. The latest quarterly results reported net sales and net profit for June 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 4 Cr (Quarterly Results - Jun 2025) <BR>Net Profit: 7 Cr (Quarterly Results - Jun 2025) <BR>Market-cap: INR 39 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 3.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.80 <BR>Return on Equity: 7.29% <BR>Price to Book: 0.19 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Murae Organisor?

Murae Organisor's peers include Kabra Drugs, Parmax Pharma, ANG Lifesciences, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, Vista Pharma, Chandra Bhagat, and Sandu Pharma. Murae Organisor has a Good growth rating but the lowest returns among its peers, with a 1-year return of -72.86%.

Peers: The peers of Murae Organisor are Kabra Drugs, Parmax Pharma, ANG Lifesciences, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, Vista Pharma, Chandra Bhagat, and Sandu Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Kabra Drugs and Roopa Industries, while Average management risk is found at Rajnish Wellness and Sandu Pharma. Below Average management risk is noted at Parmax Pharma, ANG Lifesciences, Vivo Bio Tech, Vista Pharma, Chandra Bhagat, and the rest. Growth is Excellent at Kabra Drugs and Roopa Industries, Good at Murae Organisor, Average at Rajnish Wellness and Sandu Pharma, and Below Average at Parmax Pharma, ANG Lifesciences, Vivo Bio Tech, Vista Pharma, Chandra Bhagat, and the rest. Capital Structure is Good at Sandu Pharma, Below Average at Kabra Drugs, Parmax Pharma, ANG Lifesciences, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, Vista Pharma, Murae Organisor, Chandra Bhagat, and the rest.<BR><BR>Return Snapshot: Parmax Pharma has the highest 1-year return at 273.20%, while Murae Organisor has the lowest at -72.86%. Murae Organisor's return is significantly lower than all peers. Additionally, the six-month return is negative for Kabra Drugs, Rajnish Wellness, Vivo Bio Tech, Roopa Industries, Vista Pharma, and Murae Organisor.

How big is Murae Organisor?

As of 31st August, Murae Organisor Ltd has a market capitalization of 39.00 Cr, with recent Net Sales of 858.58 Cr and a Net Profit of 15.20 Cr. Shareholder's Funds are 208.46 Cr and Total Assets amount to 651.96 Cr as of March 2025.

As of 31st August, Murae Organisor Ltd has a market capitalization of 39.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Murae Organisor reported Net Sales of 858.58 Cr and a Net Profit of 15.20 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 208.46 Cr and Total Assets of 651.96 Cr.

Should I buy, sell or hold Murae Organisor?

How has been the historical performance of Murae Organisor?

Murae Organisor has shown significant growth in net sales, increasing from 55.11 Cr in March 2020 to 854.82 Cr in March 2025, alongside improvements in profitability metrics, despite challenges in cash flow management. The company's equity capital rose substantially, reflecting a strong capital base during this recovery phase.

Answer:<BR>The historical performance of Murae Organisor shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Murae Organisor's net sales have dramatically increased from 55.11 Cr in March 2020 to 854.82 Cr in March 2025, indicating a substantial growth trajectory. However, total operating income followed a similar pattern, rising from 50.70 Cr in March 2019 to 854.82 Cr in March 2025. The company has maintained a consistent zero in raw material costs and other operating income throughout this period. The total expenditure, excluding depreciation, has also seen a rise, from 47.40 Cr in March 2019 to 844.79 Cr in March 2025. Operating profit (PBDIT) has fluctuated, with a notable recovery to 10.03 Cr in March 2025 after experiencing losses in previous years. Profit before tax has similarly improved to 10.03 Cr in March 2025, up from just 0.07 Cr in March 2024. Profit after tax has also shown a positive trend, reaching 7.52 Cr in March 2025 compared to only 0.05 Cr in March 2024. The company's equity capital has increased significantly from 0.31 Cr in March 2019 to 185.90 Cr in March 2025, reflecting a strong capital base. On the balance sheet, total liabilities rose from 23.25 Cr in March 2019 to 119.86 Cr in March 2024, while total assets mirrored this increase, reaching 119.86 Cr in March 2024. Cash flow from operating activities has been negative in recent years, with a notable outflow of 15.00 Cr in March 2024, although financing activities provided a net inflow of 28.00 Cr in the same period. Overall, Murae Organisor's financial performance indicates a recovery and growth phase, particularly in sales and profitability metrics, despite challenges in cash flow management.

Are Murae Organisor latest results good or bad?

Murae Organisor's latest results show strong net sales growth of over 225,000% and a 296% increase in Profit After Tax, indicating improved profitability. However, a 62.5% decline in Profit Before Tax raises concerns about sustainability, leading to a current stock rating of 'Hold'.

Murae Organisor's latest results present a mixed picture. On one hand, the company has reported a remarkable increase in net sales, reaching Rs 519.52 crore, which reflects an extraordinary year-on-year growth of over 225,000%. This indicates strong market performance and suggests that the company is successfully expanding its sales.<BR><BR>Additionally, the Profit After Tax (PAT) of Rs 7.44 crore represents a substantial increase of nearly 296% compared to the average PAT of the previous four quarters. This is the highest PAT recorded in the last five quarters, indicating a positive trend in profitability and improved earnings for shareholders, as reflected in the Earnings per Share (EPS) of Rs 0.07.<BR><BR>However, there are notable concerns regarding the Profit Before Tax (PBT), which has decreased by 62.5% from the previous average, falling to Rs 0.94 crore. A significant portion of this PBT is attributed to non-operating income, which raises questions about the sustainability of the company’s core business operations. <BR><BR>Overall, while Murae Organisor shows strong sales growth and improved profitability metrics, the decline in PBT and reliance on non-operating income suggest potential challenges ahead. The stock is currently rated as a 'Hold', indicating that while there are positive aspects, caution may be warranted.

When is the next results date for Murae Organisor?

Murae Organisor will declare its results on 22 August 2025.

Murae Organisor will declare its results on 22 August 2025.

Is Murae Organisor overvalued or undervalued?

As of August 14, 2025, Murae Organisor is considered undervalued with a PE Ratio of 16.86 and an EV to EBIT of 11.47, making it an attractive investment opportunity despite a year-to-date stock performance of -70.05% compared to the Sensex's 3.15%.

As of 14 August 2025, Murae Organisor has moved from a grade of risky to very attractive, indicating a significant improvement in its valuation outlook. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE Ratio of 16.86, an EV to EBIT of 11.47, and a PEG Ratio of 0.01, which suggests that the stock is trading at a low valuation relative to its growth potential.<BR><BR>In comparison to its peers, Murae Organisor stands out with a much lower PE Ratio than Sun Pharma (34.24) and Divi's Lab (70.57), both of which are classified as expensive. Additionally, Murae's EV to EBITDA ratio of 11.47 is more favorable than many competitors, reinforcing its undervaluation status. Despite recent poor stock performance against the Sensex, with a year-to-date return of -70.05% compared to the Sensex's 3.15%, the valuation metrics suggest that Murae Organisor presents a compelling investment opportunity at its current price.

What is the technical trend for Murae Organisor?

As of June 2, 2025, Murae Organisor's technical trend is mildly bullish, supported by positive weekly and monthly MACD and Bollinger Bands, despite some short-term bearish signals from daily moving averages and mixed KST indicators.

As of 2 June 2025, the technical trend for Murae Organisor has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD is mildly bullish. Bollinger Bands are bullish on both weekly and monthly time frames, indicating upward price momentum. The Dow Theory also reflects a mildly bullish stance on both weekly and monthly charts. However, the daily moving averages are mildly bearish, which suggests some short-term weakness. The KST shows a bearish signal on the weekly but is bullish on the monthly, indicating mixed signals across time frames. Overall, the current technical stance is mildly bullish, driven primarily by the positive MACD and Bollinger Bands on the weekly and monthly charts.

Who are the top shareholders of the Murae Organisor?

The top shareholders of Murae Organisor include individual investors with 60.02% of the shares, while Ifl Enterprises Limited holds 7.34%. Auxilia Pharmaceuticals Private Limited is the promoter with a reported stake of 0.0%, and there are no institutional holdings.

The top shareholders of Murae Organisor include individual investors, who hold a significant 60.02% of the shares. The highest public shareholder is Ifl Enterprises Limited, with a holding of 7.34%. Additionally, Auxilia Pharmaceuticals Private Limited is noted as the promoter with the highest holding, although their stake is listed as 0.0%. There are no institutional holdings from mutual funds or foreign institutional investors.

What is the bonus history of the Murae Organisor?

Murae Organisor issued a 1:1 bonus on August 9, 2021, with a record date of August 10, 2021, meaning shareholders received an additional share for each share owned as of that date.

Murae Organisor has a bonus history that includes a 1:1 bonus issue announced on August 9, 2021. The record date for this bonus was August 10, 2021. This means that shareholders received an additional share for every share they owned as of the record date. If you have any more questions about the company or its financials, feel free to ask!

Has Murae Organisor declared dividend?

No Dividend History Available